A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development

Abstract

The purpose of this article is to report an evaluation of the teratogenic and fetotoxic potential of medezepam in humans based on pregnant women who used very large doses of medazepam for a suicide attempt. All self-poisoned patients were cared for at the Department of Toxicology Internal Medicine, Koranyi Hospital, a toxicological inpatients clinic in Budapest, Hungary, between 1960 and 1993. Pregnant women were identified from self-poisoned subjects admitted from a population base of three million people of Budapest and the surrounding region. The rates of congenital abnormalities (CAs), intrauterine fetal development, cognitive and behavioral status in children born to mothers who attempted suicide with medazepam alone or in combination with other drugs during pregnancy was compared in their sib controls. Between 1980 and 1993, 835 pregnant women in our study attempted suicide during pregnancy with drugs. Of these, 314 delivered live-born infants and 283 were examined and/or evaluated. Thirty-two (3.8%) of these 835 pregnant women used medazepam with or without other drugs for self-poisoning; 10 of these women delivered live-born babies. The dose of medazepam used for the suicide attempt ranged between 60 and 500 mg, with a mean of 276 mg. Eight of the 32 suicide attempts involving medazepam occurred between the 4th and 12th postconceptional weeks. Of the 10 live-born exposed children, one was affected with congenital inguinal hernia; one of the 13 sib controls had a lethal hydronephrosis. No adverse effects were observed on intrauterine growth, cognitive status, or behavioral deviations in the 10 children born to mothers who attempted suicide with medazepam during pregnancy. Very large doses of medazepam were used for self-poisoning during pregnancy. These doses did not increase the rate of CAs even though eight mothers attempted suicide during the most critical period for production of CAs. No fetotoxic, including neurotoxic, effects of exposure of live-born children to a very large dose of medazepam were observed. Our experiences show the feasibility and benefits of use of the self-poisoning model in estimating human teratogenic and fetotoxic risks of drugs.

Keywords

medazepam congenital abnormalities birth weight pregnancy age cognitive and behavioral development suicide attempt during pregnancy

Get full access to this article

View all access options for this article.

References

Banarjee U (1975) Conditional learning in young rats born of drug-addicted parents and raised on addictive drugs. Psychopharmacol (Berl) 42: 113–116.

Briggs GG Freeman RK Yaffe S (2005) Drugs in Pregnancy and Lactation: a reference guide to fetal and neonatal risk, seventh ed. Baltimore: Lippincott Williams and Wilkins.

Czeizel AE (1986) Self-poisoning as a model for the study of mutagenicity and teratogenicity of chemicals on human beings. In: C Ramel B Lambert J Magnusson . (eds), Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis. Alan R.Liss: New York. pp. 237–244.

Czeizel AE Gidai J Petik D Timmermann G Puhó EH (2008) Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Ind Health 24: 11–28.

Czeizel AE Petik D Puhó E (2004) Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Cent Eur J Public Health 12: 79–83.

Czeizel AE Rockenbauer M Siffel, Cs, Varga, E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 63: 176–185.

Czeizel AE Tomcsik J Tímár L (1997) Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol 90: 195–201.

Erös E Czeizel AE Rockenbauer M Sorensen HT Olsen J (2002) A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 101: 147–154.

FDA (1980) Food and Drug Administration. Fetal Risk Summary. Fed Regist 44: 37434–37467.

10.

Friedman JM Polifka JE (1996) The Effects of Drugs on the Fetus and Nursing Infant. Johns Hopkins Univ. Press: Baltimore.

11.

Jorgensen NP Thurmann-Nielsen E Walstad RA (1988) Pharmacokinetics and distribution of diazepam and oxazepam in early pregnancy. Acta Obstet Gynecol Scand 67: 493–497.

12.

Kanto JH (1982) Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 23: 354–380.

13.

Kanto J Erkkola R Sellman R (1973) Accumulation of diazepam and n-demethyldiazepam in the fetal blood during labour. Ann Clin Res 5: 375–379.

14.

Lendvay A Czeizel AE (1992) A behavioural teratologic study on offspring of self-poisoned pregnant women. Acta Paediatr Hung 32: 347–369.

15.

Nicholson AN (1981) The use of short- and long-acting hypnotics in clinical medicine. Br J Clin Pharmacol 11: 615–695.

16.

Shepard TH Lemire RJ (2004) Catalog of Teratogenic Agents, eleventh ed. Baltimore: Johns Hopkins Univ. Press.

17.

Szegal B (1980) Diagnostic of psychomotor development. Hung Psychol 2: 148–188.

18.

USP DI (1995) Benzodiazepine. In: USP Dispensing Information, Vol. I. Drug Information for the Health Care Professional, fifteenth ed., Rockville, Md.: The US Pharmacopeial Convention. p. 460.